Lyso-Gb1 as a Long-term Prognostic Biomarker in Gaucher Disease
Clinical trial NCT02416661 · COMPLETED
Trial details
- NCT number
- NCT02416661
- Sponsor
- CENTOGENE GmbH Rostock
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-08-27
- Primary completion
- 2021-01-15
- Enrollment
- 299
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.